Consolidated Statements of Operations and Comprehensive Income (Loss) (USD $) In Thousands, except Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Revenues	$ 3,512	$ 5,024
Cost of revenues	(628)	(731)
Gross profit	2,884	4,293
Operating expenses:
Sales and marketing expenses	(101)	(286)
General and administrative expenses	(2,321)	(2,549)
Research and development costs	(390)	(717)
Charge for goodwill impairment	(3,418)	0
Other operating income	0	229
Total operating expenses	(6,230)	(3,323)
Income (loss) from operations	(3,346)	970
Other income (expense):
Gain (loss) from change in fair value of hybrid financial instruments	(4,173)	21,809
Gain (losses) on derivative liability - warrants	618	3,067
Gain from change in fair value of derivative liability - Series C and D preferred stock and debentures	289	1,841
Gain on extinguishment of debt	4,247	53
Loss on liquidation of investment in foreign subsidiary	(102)	0
Interest income, net	0	16
Total other expense	879	26,786
Net income (loss) before taxes	(2,467)	27,756
Income tax benefit	0	706
Net income (loss)	(2,467)	28,462
Deemed dividends on convertible preferred stock	0	(16)
Deemed dividends on convertible debentures	0	(726)
Net income/(loss) available to common shareholders	(2,467)	27,720
Comprehensive income (loss):
Net income	(2,467)	28,462
Foreign currency translation adjustment	0	133
Comprehensive income (loss)	$ (2,467)	$ 28,595
Net income per common share, basic and diluted:
Basic (in dollars per share)	$ 0.00	$ 0.10
Fully diluted (in dollars per share)	$ 0.00	$ 0.10
Weighted average number of common shares:
Basic (in shares)	1,585,816,122	274,625,840
Fully diluted (in shares)	1,585,816,122	274,625,840